Since the balance between CD47 and ecto-CRT expression determines the susceptibility of cancer cells to engulfment by phagocytes, based on our results (Figures 2C,D), we hypothesized that gefitinib treatment could promote phagocytosis of NSCLC cells by CD47 down-regulation. This evidence concerns the gene CD47 and cancer.